|Title||When Equal is not Equal: Generics vs. Brands|
|Author, Co-Author||Agustin Gonzalez, Mel Friedman|
|Abstract|| Are originally developed ophthalmic agents equal to generics? This course looks at the FDA ophthalmic drug development and approval process and the different routes for brand-name and generic equivalents. We review the current controversies in and
present data on the generic vs brand battle.
|Affiliation of Co-Authors|